An observational study in Steroid-Dependent Nephrotic Syndrome; Hypercalciuria, Steroid Dependent Nephrotic Syndrome and Hupercalciurea, sponsored by Sohag University. Active, not recruiting at 2 sites in Egypt. Open to participants aged 2 Years to 16 Years. Per ClinicalTrials.gov, last updated 2025-09-26.
Sponsored by Sohag University · Observational
Prevelance of hypercalciurea in children with sterorid dependent nephrotic syndrome
Prevelance of hypercalciurea in steroid dependent nephrotic syndrome
191 studies on the registry are indexed under Nephrotic Syndrome; 65 are open to participants now.
This study's planned enrollment of 50 is below the median of 125 across 59 observational studies indexed under Nephrotic Syndrome.
Browse Nephrotic Syndrome studies →Sohag University is the lead sponsor of 1,230 studies on the registry; 636 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Children diagnosed with steroid-dependent nephrotic syndrome who are being followed up at the pediatric nephrology clinic.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will undergo urine analysis to measure calcium excretion in order to assess the prevalence of hypercalciuria. No experimental treatment will be given.
Prevalence of hypercalciurea
Time frame: At enrollment
Plan to share: No — De-identified individual participant data (IPD) that underlie the results of the study will be made available upon reasonable request from the principal investigator, after publication of the main results.
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.